Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo
NCT02962180 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2016-11-11
Summary
Actually the methods for melanocyte delivery are invasive and often sophisticated. The dermarolling system with needles causing tiny microinjuries in the epidermis could offer a minimally invasive and painless method of melanocyte transplantation. The purpose of the study is to develop a new and simple method for transepidermally delivering keratinocytes and melanocytes into vitiligo skin.
Conditions
- Vitiligo
Interventions
- DEVICE
-
Dermabrasion with dermaroller
o The dermaroller is passed on the treated depigmented area. This technique is based on tiny microwounds performed using 540 microneedles (0.2mm length) which should allow the penetration of the suspension cells into the epidermis to obtain a good repigmentation.
Sponsors & Collaborators
-
Mohammed V Souissi University
lead OTHER
Principal Investigators
-
laila benzekri · Mohammed V University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2016-11-30
- Completion
- 2017-12-31
Countries
- Morocco
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo
NCT05053022 ·Status: COMPLETED ·Phase: NA
-
Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear
NCT00218868 ·Status: COMPLETED
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Vitiligo, New Treatment and Serum s100B
NCT06768840 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo
NCT05812079 ·Status: NOT_YET_RECRUITING
-
Stress Response Pathways in Vitiligo
NCT02797574 ·Status: COMPLETED ·Phase: NA
-
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine
NCT02465476 ·Status: COMPLETED ·Phase: NA
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN
-
A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT02588625 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
NCT00946699 ·Status: COMPLETED ·Phase: PHASE1
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity
NCT03741738 ·Status: COMPLETED
-
Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)
NCT05979506 ·Status: RECRUITING ·Phase: NA
-
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
NCT03740724 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo
NCT06810869 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
E-cadherin and Integrin Alpha v Beta 1 in Vitiligo
NCT05287776 ·Status: UNKNOWN ·Phase: NA
-
Intralesional Injection of STS in Treatment of Calcinosis
NCT06672822 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of FT011 in Systemic Sclerosis
NCT04647890 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of Divozilimab in Patients With Systemic Scleroderma
NCT05726630 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation
NCT04843059 ·Status: COMPLETED ·Phase: NA
-
Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy
NCT06546059 ·Status: NOT_YET_RECRUITING ·Phase: NA